A Phase 4, Single-centre, Randomised, Double-blind, Placebo-controlled, Parallel-group, Fixed-dose Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation
Latest Information Update: 09 Dec 2021
At a glance
- Drugs Linaclotide (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- Sponsors Ironwood Pharmaceuticals
- 27 Jan 2020 Status changed from completed to discontinued.
- 12 Mar 2019 Status changed from recruiting to completed.
- 10 Apr 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Dec 2018.